Schonfeld Strategic Advisors LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 577,962 shares of DNA stock, worth $5.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
577,962
Previous 73,979
681.25%
Holding current value
$5.43 Million
Previous $85,000
123.53%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DNA
# of Institutions
287Shares Held
912MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.35 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.31 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.26 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$657 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$395 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $12.1B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...